Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...

The market is responding to this breakthrough. Analysts at Exactitude Consultancy predict that the global immunotherapy ...

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer ... cell lung cancer ("NSCLC") Advancing BNT327/PM8002 combination strategy with initiation of a second antibody ...

“We aim to develop BioNTech into a global immunotherapy powerhouse with the potential to improve the ... with investigational combination therapies in two pan-tumor technology pillars: our mRNA-based ...

Although stage 2 lung cancer can involve a lymph node these lymph nodes are close to the involved lung and are called hilar lymph nodes making them removable with surgery. In certain circumstances ...

Immunotherapy can also be considered. New studies have also shown promise for using targeted therapies as adjuvant treatment after lung surgery. Specifically, using targeted therapy for patients whose ...

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with ... Surgery was scheduled to occur within 6 weeks after the last neoadjuvant treatment ...

Luis E. Raez, MD, discusses when minimal residual disease testing can be performed as an option for patients with lung cancer ...